Chromogenic Medium for Carbapenem-Resistant Bacteria Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and identifying carbapenem-resistant bacteria, particularly those producing carbapenemases like KPC and NDM-1, are inadequate in sensitivity and specificity, especially with the emergence of new resistance mechanisms such as NDM-1, and existing chromogenic media fail to detect all carbapenemase-producing strains.
Innovation Solution
A method involving a chromogenic medium with faropenem and/or doripenem, combined with cloxacillin and/or PAbetaN, is used to differentiate carbapenemase production from other resistance mechanisms by inhibiting non-carbapenemase producing bacteria, allowing for improved detection of carbapenem-resistant bacteria in biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing chromogenic media (CHROMagar KPC, COLOREX KPC) are used for detection, then the method is simple to operate, but the sensitivity and specificity are insufficient to detect all carbapenemase-producing strains including NDM-1
Solution Approach 1:
The patent changes the chemical parameters of the chromogenic medium by incorporating faropenem and/or doripenem at specific concentrations (0.065-32 mg/L) alongside existing chromogenic substrates. This parameter modification enables the medium to selectively inhibit non-carbapenemase producing bacteria while allowing carbapenemase-producing strains to grow, thereby improving detection sensitivity and specificity for all carbapenemase types including NDM-1.
Solution Approach 2:
The patent creates a composite chromogenic medium system that combines multiple components: faropenem and/or doripenem, chromogenic substrates (e.g., 5-Bromo-4-chloro-3-indoxyl-beta-D-glucopyranoside), and other culture medium ingredients. This composite formulation synergistically achieves selective inhibition of non-target bacteria while maintaining growth of carbapenemase-producing strains, resolving the contradiction between detection accuracy and medium complexity.
2Reliability
If faropenem and/or doripenem are added to the chromogenic medium at optimized concentrations, then the detection of carbapenemase-producing bacteria is improved, but the manufacturing complexity increases
Solution Approach 1:
The patent performs preliminary formulation work by pre-determining the optimal concentration ranges for faropenem (0.065-32 mg/L) and doripenem in the chromogenic medium. This preliminary optimization ensures that the medium reliably detects carbapenemase-producing bacteria while maintaining manufacturability, as the concentrations are established in advance rather than requiring complex real-time adjustments.
3Measurement precision
If the medium uses high concentrations of carbapenems to inhibit non-carbapenemase producing bacteria, then specificity improves, but carbapenemase-producing bacteria may also be inhibited
Solution Approach 1:
The patent precisely controls the concentration parameters of faropenem and/or doripenem in the range of 0.065-32 mg/L. This optimized concentration range creates a selective pressure that inhibits non-carbapenemase producing bacteria (improving specificity) while remaining below the inhibitory threshold for carbapenemase-producing strains (maintaining sensitivity). The chromogenic substrate provides additional selective pressure to enhance specificity further.
Solution Approach 2:
The patent employs a composite medium system where faropenem and/or doripenem work synergistically with chromogenic substrates and other culture components. This composite formulation creates multiple layers of selective inhibition: the carbapenem component targets non-carbapenemase producers, while the chromogenic substrate provides additional specificity. Together, they achieve both high sensitivity and specificity without requiring excessively high carbapenem concentrations that would inhibit carbapenemase-producing bacteria.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances the sensitivity and specificity of detecting carbapenem-resistant bacteria, including NDM-1 type bacteria, by allowing the growth of carbapenemase-producing bacteria while inhibiting wild-type and other resistant strains, outperforming existing chromogenic media like CHROMagar KPC and COLOREX KPC.
Implementation Method 1
The addition of faropenem in a chromogenic medium allows the growth of a majority of carbapenemase-producing bacteria, while inhibiting a majority of strains not producing any, such as wild strains, beta-producing strains
Implementation Method 2
A characterization method using a chromogenic medium comprising meropenem and/or ertapenem was proposed in application WO 2010/010083 and implemented in CHROMagar® KPC media
Data Source
AI summary
The invention relates to a method for detecting and/or identifying, in a biological sample, bacteria having a resistance to carbapenems. The method comprises the following steps consisting in: a) bringing the sample into contact with a reaction medium containing at least one chromogenic agent and faropenem and/or doripenem; b) incubating the sample and reaction medium brought into contact in step (a), such as to allow the growth of bacteria; and c) detecting the strains having a resistance to carbapenems. The medium used in step (a) also contains cloxacillin and/or a combination of cloxacillin and PAbetaN.